We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.59B
AUM Growth
+$160M
Cap. Flow
-$54.6M
Cap. Flow %
-3.43%
Top 10 Hldgs %
16.55%
Holding
226
New
31
Increased
63
Reduced
63
Closed
27

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$19M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$16.3M
3
AMRS
Amyris Inc.
AMRS
+$14.3M
4
ESTA icon
Establishment Labs
ESTA
+$12.8M
5
SQSP
Squarespace, Inc.
SQSP
+$9.51M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$20M
2
NVCR icon
NovoCure
NVCR
+$14.8M
3
SEER icon
Seer Inc
SEER
+$14.5M
4
JBLU icon
JetBlue
JBLU
+$14.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 44.51%
2 Technology 13.21%
3 Financials 6.93%
4 Consumer Discretionary 6.6%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
51
Chevron
CVX
$366B
$11.5M 0.72%
110,000
+10,000
+10% +$1.06M
RRR icon
52
Red Rock Resorts
RRR
$3.62B
$11.4M 0.71%
267,696
+106,660
+66% +$4.22M
CZR icon
53
Caesars Entertainment
CZR
$6.14B
$11.4M 0.71%
109,454
-61,571
-36% -$6.21M
BAC icon
54
Bank of America
BAC
$442B
$11.1M 0.7%
270,000
-151,491
-36% -$6.21M
ARES icon
55
Ares Management
ARES
$30.9B
$10.8M 0.68%
170,000
-30,000
-15% -$1.68M
CHGG icon
56
Chegg
CHGG
$102M
$10.6M 0.66%
127,174
-3,537
-3% -$293K
FRC
57
DELISTED
First Republic Bank
FRC
$10.5M 0.66%
55,967
+5,399
+11% +$992K
SMAR
58
DELISTED
Smartsheet Inc.
SMAR
$10.2M 0.64%
140,884
+36,061
+34% +$2.25M
SHOO icon
59
Steven Madden
SHOO
$3.55B
$10.2M 0.64%
232,403
+24,436
+12% +$1.01M
SQSP
60
DELISTED
Squarespace, Inc.
SQSP
$9.92M 0.62%
+167,017
New +$9.51M
BX icon
61
Blackstone
BX
$110B
$9.89M 0.62%
101,851
+21,851
+27% +$1.94M
CLAR icon
62
Clarus
CLAR
$143M
$9.08M 0.57%
353,276
+96,066
+37% +$2.05M
STKL
63
DELISTED
SunOpta
STKL
$8.96M 0.56%
731,600
+75,754
+12% +$989K
VICI icon
64
VICI Properties
VICI
$29.4B
$8.91M 0.56%
287,225
+27,225
+10% +$844K
COUP
65
DELISTED
Coupa Software Incorporated
COUP
$8.71M 0.55%
33,246
+3,879
+13% +$961K
VTGN icon
66
VistaGen Therapeutics
VTGN
$12.8M
$8.68M 0.54%
91,796
+19,763
+27% +$1.46M
LVTX
67
DELISTED
LAVA Therapeutics
LVTX
$8.51M 0.53%
781,867
-32,973
-4% -$409K
NVDA icon
68
NVIDIA
NVDA
$5.42T
$8.43M 0.53%
421,440
-19,120
-4% -$306K
VMEO
69
DELISTED
Vimeo
VMEO
$8.33M 0.52%
+169,972
New +$7.82M
MS icon
70
Morgan Stanley
MS
$340B
$8.25M 0.52%
90,000
+65,000
+260% +$5.57M
TWLO icon
71
Twilio
TWLO
$36.6B
$7.76M 0.49%
19,679
+2,424
+14% +$842K
CDLX icon
72
Cardlytics
CDLX
$21.5M
$7.74M 0.49%
6,101
-398
-6% -$449K
BILL icon
73
BILL Holdings
BILL
$4.78B
$7.69M 0.48%
+41,993
New +$6.58M
AFG icon
74
American Financial Group
AFG
$12.1B
$7.4M 0.46%
59,347
– –
EVBG
75
DELISTED
Everbridge, Inc. Common Stock
EVBG
$7.14M 0.45%
52,448
+11,200
+27% +$1.4M
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Nicholas Investment Partners held 226 positions worth $1.59B, up 11% from $1.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nicholas Investment Partners withdrew a net $54.6M in Q2 2021, closing 27 positions and reducing 63 holdings. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Mirati Therapeutics, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2021 buy was Mirati Therapeutics, Inc. Common Stock: 118,591 shares worth $19.2M.
  • Nicholas Investment Partners added most to Amyris Inc. in Q2 2021, an estimated $14.3M increase.
  • Nicholas Investment Partners's biggest Q2 2021 reduction was NovoCure, cutting an estimated $14.8M.
  • Nicholas Investment Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 17% of its $1.59B portfolio in Q2 2021.
  • Nicholas Investment Partners opened 31 new positions and closed 27 in Q2 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.59B.

Based on Nicholas Investment Partners's 13F filing for Q2 2021, filed 10 Aug 2021.